Update on the molecular targeted therapy for cervical cancer / 中国癌症杂志
China Oncology
;
(12): 73-80, 2015.
Artículo
en Chino
| WPRIM
| ID: wpr-461599
ABSTRACT
Cervical cancer is one of the most common and deadliest cancers in females worldwide. Despite the treatment methods of surgery, radiotherapy and chemotherapy are maturing, the prognosis of patients with recurrent, advanced or metastatic cervical cancer remains poor. Molecular targeted therapy provides new hope for these patients. This review focuses on the advances in agents targeting vascular endothelial growth factor pathway, epidermal growth factor receptor, mammalian target of rapamycin, histone deacetylases and cyclooxygenase-2 in cervical cancer.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio pronóstico
Idioma:
Chino
Revista:
China Oncology
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS